healthmedicinet

Daily News and Tips

Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis

1 Mapi, De Molen 84, Houten, 3995, AX, The Netherlands

2 Novartis Pharma AG, Basel, CH-4002, Switzerland

3 University of Oxford, Oxford, OX3 7LE, United Kingdom

For all author emails, please log on.